Honasa Consumer (NSE: HONASA) Targets 30% Q1 FY27 Growth; Shares Trade Near ₹467 After 64% YTD Rally

Honasa Consumer shares traded near ₹467 on July 9, 2026, extending a strong 2026 rally. The Mamaearth parent has climbed roughly 64% since the start of the year. Management now guides for around 30% year-on-year revenue growth in Q1 FY27. Mamaearth itself is projected to grow in the high teens, with offline channels adding momentum. The stock’s 52-week range spans ₹248.40 to ₹477.00, reflecting a sharp turnaround from early-2026 lows.

Honasa Consumer Guidance Signals Accelerating Momentum

Honasa Consumer’s (HONASA.NS) Q1 FY27 growth target builds on a blowout Q4 FY26 performance. Consolidated revenue rose 23% year-on-year to ₹657 crore in that quarter. EBITDA jumped 186% to ₹77 crore, with the margin expanding from 5.1% to 11.7%. Profit after tax jumped 178% to ₹69 crore, with PAT margin reaching 10.6%.

• Focus categories grew 35% year-on-year, outpacing overall brand growth.
• The Derma Co. brand crossed ₹750 crore in annualized revenue run rate.

Management called Q4 FY26 its highest-ever quarterly revenue and EBITDA period. That marked the third straight quarter of over 20% growth for Honasa Consumer.

Full-Year FY26 Results Show Sharp Profitability Gains

Honasa Consumer’s full-year FY26 numbers confirm the same profitability trend seen quarterly. Annual revenue rose 16% year-on-year to ₹2,392 crore, up from ₹2,067 crore in FY25. EBITDA more than tripled, surging 237% to ₹231 crore, with margin expanding to 9.7% from 3.3%. Profit after tax climbed 175% to ₹200 crore, up from ₹73 crore a year earlier.

Honasa eyes stronger Q1 FY27, guided by offline push and steady brand demand.@GhazalAlagh @VarunAlagh

Read More: https://t.co/FKsIYgSY2N pic.twitter.com/IsFnsQtPIj

— Ascendants (@AscendantsDotIn) July 9, 2026

The board approved Honasa Consumer’s maiden final dividend of ₹3 per share, worth 30%. That payout represents 51.2% of FY26 standalone profit after tax. Net cash from operations rose to ₹141 crore in FY26, up from ₹102 crore in FY25. These results give investors a clearer profitability roadmap heading into FY27.

Expansion Into Nutraceuticals and Distribution Growth

Honasa Consumer recently approved acquiring a 58% stake in Fluence Pharma for ₹135 crore. That deal marks the company’s formal entry into the nutraceuticals segment. Honasa also incorporated a new subsidiary, Honasa Health Private Limited, for B2C nutraceutical operations. This move diversifies revenue beyond core beauty and personal care categories.

Distribution expansion remains a parallel growth lever for Honasa Consumer this year. General trade outlet coverage has reached approximately 200,000 stores nationwide. Management sees a multi-year opportunity to scale that toward 500,000 outlets. Goldman Sachs has set a longer-term revenue target of ₹5,500 crore by FY31 for the company.

Analyst Sentiment and Peer Comparison

Brokerages have turned increasingly bullish on Honasa Consumer following its Q4 FY26 results. Jefferies (NYSE: JEF) and CLSA both flagged additional upside potential after the strong quarterly show. Simply Wall St’s fair value estimate for the stock now sits near ₹565. The company trades at a trailing P/E of roughly 75 times, above FMCG peer averages.

Honasa Consumer competes with listed peers like Godrej Consumer Products, Dabur India, and Colgate-Palmolive India. It also competes directly with Nykaa (FSN E-Commerce Ventures) in India’s digital-first beauty space. The company’s premium valuation reflects investor confidence in its accelerating growth trajectory. Continued execution on Q1 FY27 guidance will be critical to sustaining that premium.

Final Thoughts

Honasa Consumer’s 30% Q1 FY27 growth target reflects genuine operational momentum, not just optimistic guidance. Strong Q4 FY26 margins, a maiden dividend, and the Fluence Pharma acquisition all point to a maturing business model. The stock’s 64% year-to-date rally already prices in much of this optimism, keeping valuations elevated. Investors should watch Q1 FY27 results closely to confirm whether Mamaearth and offline channels can sustain this pace. Distribution expansion toward 500,000 outlets remains the key long-term catalyst to monitor.

Disclaimer:

The content shared by Meyka AI PTY LTD is solely for research and informational purposes. Meyka is not a financial advisory service, and the information provided should not be considered investment or trading advice